These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35469600)

  • 1. United States marijuana legalization and opioid mortality epidemic during 2010-2020 and pandemic implications.
    Bleyer A; Barnes B; Finn K
    J Natl Med Assoc; 2022 Aug; 114(4):412-425. PubMed ID: 35469600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic.
    Bleyer A; Barnes B; Finn K
    J Opioid Manag; 2024; 20(2):119-132. PubMed ID: 38700393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State marijuana laws and opioid overdose mortality.
    Chihuri S; Li G
    Inj Epidemiol; 2019; 6():38. PubMed ID: 31497489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marijuana legalization and opioid deaths.
    Mathur NK; Ruhm CJ
    J Health Econ; 2023 Mar; 88():102728. PubMed ID: 36808015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment.
    Bao Y; Zhang H; Bruera E; Portenoy R; Rosa WE; Reid MC; Wen H
    JAMA Oncol; 2023 Feb; 9(2):206-214. PubMed ID: 36454553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid Death Rate Acceleration in Jurisdictions Legalizing Marijuana Use-Reply.
    Bradford AC; Abraham A; Bagwell Adams G
    JAMA Intern Med; 2018 Sep; 178(9):1281-1282. PubMed ID: 30193247
    [No Abstract]   [Full Text] [Related]  

  • 7. Exploring the effect of Colorado's recreational marijuana policy on opioid overdose rates.
    Alcocer JJ
    Public Health; 2020 Aug; 185():8-14. PubMed ID: 32505041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recreational cannabis legalization and transitions in cannabis use: findings from a nationally representative longitudinal cohort in the United States.
    Gunadi C; Zhu B; Shi Y
    Addiction; 2022 Oct; 117(10):2651-2659. PubMed ID: 35618659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort.
    Lopez CD; Boddapati V; Jobin CM; Hickernell TR
    J Am Acad Orthop Surg; 2021 Feb; 29(4):e188-e197. PubMed ID: 32404683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In our war against the opioid epidemic, could 'weed' be a winner?
    Ding DD; Balkrishnan R; Diaby V
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):423-429. PubMed ID: 32799573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.
    Liang D; Bao Y; Wallace M; Grant I; Shi Y
    Addiction; 2018 Nov; 113(11):2060-2070. PubMed ID: 29989239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Marijuana Legalization in Oklahoma: Effects on Neonatal Exposure to Opiates.
    DeShea L; Rolfs S; McCoy M; Beasley WH; Szyld E; Makkar A
    Am J Perinatol; 2024 May; 41(S 01):e1069-e1074. PubMed ID: 36452967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.
    Nguyen HV; McGinty EE; Mital S; Alexander GC
    JAMA Health Forum; 2024 Jan; 5(1):e234897. PubMed ID: 38241056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marijuana, Opioid, and Alcohol Use Among Pregnant and Postpartum Individuals Living With HIV in the US.
    Yee LM; Kacanek D; Brightwell C; Haddad LB; Jao J; Powis KM; Yao TJ; Barr E; Broadwell C; Siminski S; Seage GR; Chadwick EG;
    JAMA Netw Open; 2021 Dec; 4(12):e2137162. PubMed ID: 34860242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-legalizing cannabis for medical use in the USA.
    Victor B; Hager K; Stacy S
    J Public Health (Oxf); 2022 Aug; 44(3):679-684. PubMed ID: 33823039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
    Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M
    Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the public health impacts of legalizing recreational cannabis use in the United States.
    Hall W; Lynskey M
    Addiction; 2016 Oct; 111(10):1764-73. PubMed ID: 27082374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct democracy and the adoption of recreational marijuana legalization in the United States, 2012-2019.
    Vann B
    Int J Drug Policy; 2022 Apr; 102():103583. PubMed ID: 35131689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study.
    Hsu G; Kovács B
    BMJ; 2021 Jan; 372():m4957. PubMed ID: 33504472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata.
    Ali MM; McClellan C; Mutter R; Rees DI
    Health Econ; 2023 Feb; 32(2):277-301. PubMed ID: 36335085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.